Bright Minds Biosciences DRUG Ratios (2020-2026)

NASDAQ DRUG
$66.44 -1.57 (-2.32%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Bright Minds Biosciences Quarterly Ratios

Periods 23 quarters
Latest Jun 2026

Bright Minds Biosciences ratios data for the quarter ended Jun 2026. These financial ratios cover 23 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg.
17.00M14.07M10.76M8.10M8.09M8.89M7.95M6.84M5.71M5.10M4.95M4.72M4.53M23.14M40.58M38.62M49.62M63.26M146.47M226.06M
Valuation
Price to EarningsP/E
-6.49-1.08-4.303.5725.68-2.550.01M69.5028.62-47.25-99.12-58.11-142.83
Price to BookP/B
4.162.401.601.081.881.130.821.221.211.201.060.911.303.944.203.167.779.312.482.41
Enterprise Value
48.39M16.45M4.56M0.40M6.28M0.88M-1.72M0.99M0.92M0.35M0.06M-0.49M1.10M121.51M124.38M81.04M402.94M532.04M331.35M313.50M
EV to EBIT
-0.91-0.17-0.290.05-3.12-0.530.00M52.9718.79-40.33-88.50-34.56-83.53
EV to EBITDA
-0.91-0.17-0.290.05-3.12-0.530.00M52.9718.79-40.33-88.50-34.56-83.53
Market Capitalization
64.09M28.45M13.62M7.18M15.19M9.14M5.44M7.04M5.95M5.32M4.46M4.04M5.29M162.96M163.18M118.12M463.19M595.90M557.18M536.03M
Price to FCFP/FCF
33.767.244.733.209.314.664.865.73-0.628.817.47-22.99-2.23152.3396.5546.71-39.56-142.88-82.64-88.90
EV to FCF
25.494.191.590.183.850.45-1.530.81-0.100.580.102.79-0.46113.5973.5932.05-34.41-127.57-49.15-51.99
EV to CFO
25.494.191.590.183.850.45-1.530.81-0.100.580.102.79-0.46113.5973.5932.05-34.41-127.57-49.15-51.99
Return Ratios
Return on Capital Employed [ROCE]ROCE
-45.99%-2.79%1.15%12.09%-6.88%-15.04%-14.81%-13.09%
Return on Assets [ROA]ROA
-132.69%-112.95%-42.06%-2.75%1.14%11.48%-6.64%-14.76%-14.53%-12.90%